semaglutide news october 16 2025 Semaglutide: The Drug of Today and a Steppingstone to Tomorrow FDA approves obesity drug that

They instruct cells to repair, regenerate, and balance key functions throughout the body

Put it all together real competition, dropping prices and the GLP-1 dynamic is looking much more like market economics than is usually seen in health care

The FDA updated semaglutide labeling in 2023 to add language about the risk of ileus, following adverse event reports

The brand's "GLP-1 pathway support" positioning suggests their botanical ingredients may influence metabolic pathways - this is not the same mechanism as directly activating GLP-1 receptors

5-Amino-1MQ enhances mitochondrial energy and NAD+ to drive metabolism

Together, these form GSH, the most active form of glutathione